Infection Control Today® Editorial Staff

Spanish-speaking patients face significantly higher risks of contracting serious infections during hospital stays, even when interpreter services are provided, according to new research presented at the 2025 APIC Annual Conference.

As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.

In a strong statement, Devin Jopp, CEO of APIC, and Leah Binder, CEO of The Leapfrog Group, urge health care leaders to strengthen their commitment to infection prevention and control (IPC).

From April 5 to 8, 2025, thousands of perioperative nurses will gather in Boston for the 2025 AORN Global Surgical Conference & Expo—a transformational experience designed to elevate nursing practice, build lifelong connections, and advance surgical care.

A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.

Dr Noah Greenspan discusses the evolving understanding of long COVID, current treatment strategies, diagnostic challenges, and the critical need for research and awareness in post-viral syndromes.

Budget cuts to the CDC threaten disease surveillance, outbreak response, and public health programs, increasing risks from measles, avian flu, and future pandemics while straining health care infrastructure nationwide.

Measles cases in Canada are rising, with 227 infections reported in early 2025. Public health officials urge vaccination to prevent outbreaks, severe complications, and further community transmission.

HHS’s move to eliminate public input on health policies threatens patient safety and infection prevention. APIC demands transparency, accountability, and urgent action to protect public health.

The recent measles-related death in Texas has reignited fears about the consequences of declining vaccination rates and misinformation. Once declared eliminated in the US, measles is resurging with over 150 cases and climbing. APIC warns: this crisis is preventable—but only if we act now.

The Advanced Leadership Certification in Infection Prevention (AL-CIP) validates leadership, expertise, and strategic decision-making in infection control. Learn why top professionals pursue this certification and how it enhances careers, and apply for yours today!

GermZAPP is an affordable hand hygiene system designed to educate, monitor, and encourage adherence in schools, nursing homes, and health care settings, effectively addressing gaps in infection control.

APIC congratulates Secretary Robert F. Kennedy, Jr on his appointment and urges support for infection prevention priorities, including NHSN funding, workforce development, nursing home IPC improvements, medical device cleaning standards, and global health collaboration.

Sepsis is a leading cause of death, often misdiagnosed and mistreated. Systems immunology and precision medicine offer hope for early diagnosis, personalized treatment, and better patient outcomes.

APIC warns that the HHS gag order on CDC communications endangers public health, delaying critical infection updates and weakening outbreak response amid rising tuberculosis, avian flu, Ebola, and measles threats.

A CNA unknowingly worked while infectious with mpox, exposing 56 residents. Yet, no secondary infections occurred, highlighting the power of standard precautions in healthcare settings.

The American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) released comprehensive infection control guidelines for pain procedures, emphasizing prevention, early recognition, multidisciplinary collaboration, and judicious antibiotic use to enhance patient safety and healthcare outcomes.

EvaClean partners with Microsplitting Ltd. to distribute its advanced disinfection systems and absorbents, revolutionizing infection prevention across health care, education, hospitality, and industrial sectors worldwide.

Barinthus Bio’s Phase 2b trial shows VTP-300’s potential to achieve functional cures for chronic hepatitis B, with promising HBsAg loss, safety, and durable immune responses.

From advanced sterilization methods to combating antimicrobial resistance, Infection Control Today’s top articles of 2024 delivered actionable strategies for safer healthcare environments and improved patient outcomes.

IDWeek 2024 continues to give encouraging studies. Check out several more from CSL Seqirus and Shionogi.

Learn how Pula General Hospital in Croatia championed infection prevention and environmental hygiene and celebrated Clean Hospitals Day to honor cleaning staff and promote advanced practices for exceptional patient care and safety.

Discover how a groundbreaking color additive for disinfectant wipes improved hospital cleanliness by 69.2%, reduced microbial presence by nearly half, and enhanced cleaning efficiency—all without disrupting workflows.

A CDC report reveals 25 years of splash pad-linked waterborne outbreaks, highlighting risks from pathogens like Cryptosporidium. Prevention requires better hygiene, water treatment, and public health strategies.

Infection Control Today’s Infection Intel learns more about Stryker’s Oculan Lighting Platform and Hexaware Technologies’ Clinical Data Automation as a Solution (CDAaaS).

Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.

At IDWeek, Invivyd highlighted Pemgarda’s effectiveness under FDA Emergency Use Authorization for immunocompromised patients, demonstrating efficacy against evolving COVID-19 variants since the Omicron strain.

Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.

Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.

Phyllis Arthur, MBA, and David Thomas, CFA, from BIO provide insights into challenges, investment trends, and policy considerations for developing vaccines targeting rare diseases.